TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors

Binding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to the plasma membrane TRAIL-R1/-R2 selectively kills tumor cells. This discovery led to evaluation of TRAIL-R1/-R2 as targets for anti-cancer therapy, yet the corresponding clinical trials were disappointing. Meanwhile, it e...

Full description

Bibliographic Details
Main Authors: Ufuk Mert, Alshaimaa Adawy, Elisabeth Scharff, Pierre Teichmann, Anna Willms, Verena Haselmann, Cynthia Colmorgen, Johannes Lemke, Silvia von Karstedt, Jürgen Fritsch, Anna Trauzold
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/8/1167
_version_ 1797708327808925696
author Ufuk Mert
Alshaimaa Adawy
Elisabeth Scharff
Pierre Teichmann
Anna Willms
Verena Haselmann
Cynthia Colmorgen
Johannes Lemke
Silvia von Karstedt
Jürgen Fritsch
Anna Trauzold
author_facet Ufuk Mert
Alshaimaa Adawy
Elisabeth Scharff
Pierre Teichmann
Anna Willms
Verena Haselmann
Cynthia Colmorgen
Johannes Lemke
Silvia von Karstedt
Jürgen Fritsch
Anna Trauzold
author_sort Ufuk Mert
collection DOAJ
description Binding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to the plasma membrane TRAIL-R1/-R2 selectively kills tumor cells. This discovery led to evaluation of TRAIL-R1/-R2 as targets for anti-cancer therapy, yet the corresponding clinical trials were disappointing. Meanwhile, it emerged that many cancer cells are TRAIL-resistant and that TRAIL-R1/-R2-triggering may lead to tumor-promoting effects. Intriguingly, recent studies uncovered specific functions of long ignored intracellular TRAIL-R1/-R2, with tumor-promoting functions of nuclear (n)TRAIL-R2 as the regulator of let-7-maturation. As nuclear trafficking of TRAIL-Rs is not well understood, we addressed this issue in our present study. Cell surface biotinylation and tracking of biotinylated proteins in intracellular compartments revealed that nTRAIL-Rs originate from the plasma membrane. Nuclear TRAIL-Rs-trafficking is a fast process, requiring clathrin-dependent endocytosis and it is TRAIL-dependent. Immunoprecipitation and immunofluorescence approaches revealed an interaction of nTRAIL-R2 with the nucleo-cytoplasmic shuttle protein Exportin-1/CRM-1. Mutation of a putative nuclear export sequence (NES) in TRAIL-R2 or the inhibition of CRM-1 by Leptomycin-B resulted in the nuclear accumulation of TRAIL-R2. In addition, TRAIL-R1 and TRAIL-R2 constitutively localize to chromatin, which is strongly enhanced by TRAIL-treatment. Our data highlight the novel role for surface-activated TRAIL-Rs by direct trafficking and signaling into the nucleus, a previously unknown signaling principle for cell surface receptors that belong to the TNF-superfamily.
first_indexed 2024-03-12T06:20:52Z
format Article
id doaj.art-71db7d2a031d4f8e937bcca8d1d4f662
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:20:52Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-71db7d2a031d4f8e937bcca8d1d4f6622023-09-03T02:15:41ZengMDPI AGCancers2072-66942019-08-01118116710.3390/cancers11081167cancers11081167TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death ReceptorsUfuk Mert0Alshaimaa Adawy1Elisabeth Scharff2Pierre Teichmann3Anna Willms4Verena Haselmann5Cynthia Colmorgen6Johannes Lemke7Silvia von Karstedt8Jürgen Fritsch9Anna Trauzold10Institute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyDepartment of Clinical Chemistry, University Medical Centre, Ruprecht-Karls University of Heidelberg, 68167 Mannheim, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyDepartment of General and Visceral Surgery, Ulm University Hospital, Albert-Einstein-Allee 23, 89081 Ulm, GermanyDepartment of Translational Genomics, Medical Faculty, University of Cologne, 50931 Cologne, GermanyDepartment of Infection Prevention and Infectious Diseases, University of Regensburg, 93053 Regensburg, GermanyInstitute for Experimental Cancer Research, University of Kiel, 24105 Kiel, GermanyBinding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to the plasma membrane TRAIL-R1/-R2 selectively kills tumor cells. This discovery led to evaluation of TRAIL-R1/-R2 as targets for anti-cancer therapy, yet the corresponding clinical trials were disappointing. Meanwhile, it emerged that many cancer cells are TRAIL-resistant and that TRAIL-R1/-R2-triggering may lead to tumor-promoting effects. Intriguingly, recent studies uncovered specific functions of long ignored intracellular TRAIL-R1/-R2, with tumor-promoting functions of nuclear (n)TRAIL-R2 as the regulator of let-7-maturation. As nuclear trafficking of TRAIL-Rs is not well understood, we addressed this issue in our present study. Cell surface biotinylation and tracking of biotinylated proteins in intracellular compartments revealed that nTRAIL-Rs originate from the plasma membrane. Nuclear TRAIL-Rs-trafficking is a fast process, requiring clathrin-dependent endocytosis and it is TRAIL-dependent. Immunoprecipitation and immunofluorescence approaches revealed an interaction of nTRAIL-R2 with the nucleo-cytoplasmic shuttle protein Exportin-1/CRM-1. Mutation of a putative nuclear export sequence (NES) in TRAIL-R2 or the inhibition of CRM-1 by Leptomycin-B resulted in the nuclear accumulation of TRAIL-R2. In addition, TRAIL-R1 and TRAIL-R2 constitutively localize to chromatin, which is strongly enhanced by TRAIL-treatment. Our data highlight the novel role for surface-activated TRAIL-Rs by direct trafficking and signaling into the nucleus, a previously unknown signaling principle for cell surface receptors that belong to the TNF-superfamily.https://www.mdpi.com/2072-6694/11/8/1167TRAILnuclear TRAIL-R1nuclear TRAIL-R2traffickingCRM-1
spellingShingle Ufuk Mert
Alshaimaa Adawy
Elisabeth Scharff
Pierre Teichmann
Anna Willms
Verena Haselmann
Cynthia Colmorgen
Johannes Lemke
Silvia von Karstedt
Jürgen Fritsch
Anna Trauzold
TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
Cancers
TRAIL
nuclear TRAIL-R1
nuclear TRAIL-R2
trafficking
CRM-1
title TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
title_full TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
title_fullStr TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
title_full_unstemmed TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
title_short TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
title_sort trail induces nuclear translocation and chromatin localization of trail death receptors
topic TRAIL
nuclear TRAIL-R1
nuclear TRAIL-R2
trafficking
CRM-1
url https://www.mdpi.com/2072-6694/11/8/1167
work_keys_str_mv AT ufukmert trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT alshaimaaadawy trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT elisabethscharff trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT pierreteichmann trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT annawillms trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT verenahaselmann trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT cynthiacolmorgen trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT johanneslemke trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT silviavonkarstedt trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT jurgenfritsch trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors
AT annatrauzold trailinducesnucleartranslocationandchromatinlocalizationoftraildeathreceptors